{
    "status": "accepted",
    "chain_of_thought": "[Article Type: Case Report] In this article, I found the following liver injury-related lab values and clinical outcomes: The patient is a 16-year-old female with autoimmune hepatitis (AIH) and inflammatory bowel disease (IBD), treated with vedolizumab and other drugs. Lab results from Table 1 show peak values: ALT 873 Units/L at readmission, AST 706 Units/L at readmission, ALP 219 Units/L at readmission, GGT 48 Units/L at presentation and readmission, Bilirubin (total) 3.9 mg/dL and direct 2.6 mg/dL at readmission, INR 1.4 at readmission, Albumin lowest 3.2 g/dL at presentation. Clinical outcome: The patient improved after treatment with steroids and was discharged, with follow-up showing improved lab values at 8 months, indicating recovery.",
    "patient_age": "16",
    "patient_gender": "Female",
    "suspected_drug": "vedolizumab",
    "lab_results": {
        "ALT": "873 Units/L",
        "AST": "706 Units/L",
        "ALP": "219 Units/L",
        "GGT": "48 Units/L",
        "Bilirubin": "Total bilirubin 3.9 mg/dL, Direct bilirubin 2.6 mg/dL",
        "INR": "1.4",
        "Albumin": "3.2 g/dL"
    },
    "clinical_outcome": "Improved/Discharged",
    "AI_confidence_score": 0.95
}